Health Care & Life Sciences » Biotechnology | Exelixis Inc.

Exelixis Inc.

Exelixis Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
 -
Market Cap
 -
Shares Outstanding
 298.04 M
Public Float
 255.61 M
Exelixis Inc.
Stock Exchange NASDAQ Stock Market
EPS
 $2.08
Market Cap
 $6.37 B
Shares Outstanding
 301.77 M
Public Float
 289.93 M

Profile

Address
1851 Harbor Bay
Parkway Alameda California 94502
United States
Employees -
Website http://www.exelixis.com
Updated 07/08/2019
Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S.

Financials

View All
Created with Highcharts 5.0.14Exelixis Inc.Net Income. Fiscal year is January-December. All values USD Thousands.244 760244 760268 542268 542161 744161 74470 22270 222153 860153 860690 070690 0702013201420152016201720180200k400k600k800k
Created with Highcharts 5.0.14Exelixis Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.31 33831 33825 11125 11137 17237 172191 454191 454452 677452 677845 742845 7422013201420152016201720180200k400k600k800k1 000k

Charles M. Cohen
Independent Director
Michael M. Morrissey
President, Chief Executive Officer & Director
View All

StatInvestor

Privacy Policy
Feedback

© 2025 StatInvestor All Rights Reserved.